A potential therapeutic target for FLT3-ITD AML: PIM1 Kinase

Por Fathi, Amir T., Arowojolu, Omotayo, Swinnen, Ian, Sato, Takashi, Rajkhowa, Trivikram, Small, Donald, Marmsater, Fredrik, Robinson, John E., Gross, Stefan David, Martinson, Matthew, Allen, Shelley, Kallan, Nicholas C., Levis, Mark
Publicado em 2011

Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability

Por Hicken, Erik J., Marmsater, Fred P., Munson, Mark C., Schlachter, Stephen T., Robinson, John E., Allen, Shelley, Burgess, Laurence E., DeLisle, Robert Kirk, Rizzi, James P., Topalov, George T., Zhao, Qian, Hicks, Julie M., Kallan, Nicholas C., Tarlton, Eugene, Allen, Andrew, Callejo, Michele, Cox, April, Rana, Sumeet, Klopfenstein, Nathalie, Woessner, Richard, Lyssikatos, Joseph P.
Publicado em 2013